Barrio-Alonso, E.
Hernández-Vivanco, A.
Walton, C. C. http://orcid.org/0000-0001-8513-0207
Perea, G.
Frade, J. M.
Article History
Received: 11 April 2018
Accepted: 14 September 2018
First Online: 25 September 2018
Competing Interests
: J.M.F. is shareholder (ten percent equity ownership) of Tetraneuron, S.L., a biotech company exploiting his patent on the blockade of neuronal tetraploidy as a therapeutic approach against AD and funding his work on therapies against AD based on neuronal tetraploidy blockade. He has no other competing interests. The other authors declare that they have no competing interests.